BROWSE·page 518 of 595

Browse EX-10 agreements

7,140 total material contract exhibits.


EXHIBIT 10.15

Mobility Global Inc.

MOBILITY GLOBAL INC.

as the Company

5.050% Senior Notes due 2029

5.450% Senior Notes due 2031

6.050% Senior Notes due 2036

FIRST SUPPLEMENTAL INDENTURE

Dated as of May 29, 2026

to the Indenture Dated as of May 29, 2026

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee

TABLE OF CONTENTS

Page

Article 1 DEFINITIONS 2
Section 1.01. Certain Terms Defined in the Indenture; Additional Terms 2
Article 2 FORM AND TERMS OF THE NOTES 7
Section 2.01. Form and Dating 7
Section 2.02. Paying Agent; Depository 7
Section 2.03. Registration 8
Section 2.04. Transfer and Exchange 9
Section 2.05. Terms of the Notes 9
Section 2.06. Optional Redemption 10
Section 2.07. Special Mandatory Redemption 11
Section 2.08. Offer to Repurchase Upon a Change of Control Triggering Event 12
Section 2.09. Registration Default 14
Article 3 COVENANTS 15
Section 3.01. Limitation on Liens 15

EX-10.15·10-12B/A·CIK 2090312·ACC 0001104659-26-066592·Filed May 27, 2026, 07:17 ET

EXHIBIT 10.16

Mobility Global Inc.

REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT dated May 29, 2026 (this “Agreement”) is entered into by and among Mobility Global Inc., a Delaware corporation (the “Company”), and Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and BofA Securities, Inc. (together, the “Representatives”) as representatives of the several initial purchasers named in Schedule I of the Purchase Agreement (the “Initial Purchasers”).

The Company and the Representatives are parties to the Purchase Agreement dated May 19, 2026 (the “Purchase Agreement”), which provides for the sale by the Company to the Initial Purchasers of $650,000,000 aggregate principal amount of its 5.050% Senior Notes due 2029, $650,000,000 aggregate principal amount of its 5.450% Senior Notes due 2031 and $700,000,000 aggregate principal amount of its 6.050% Senior Notes due 2036 (collectively, the “Securities”). The Securities are being issued in connection with the separation of the Company from S&P Global, Inc., a New York corporation (the “Parent”), and the distribution of 100% of the

EX-10.16·10-12B/A·CIK 2090312·ACC 0001104659-26-066592·Filed May 27, 2026, 07:17 ET

EX-10.7

VARSAL TECH, INC.

Exhibit 10.7

Form of Customer Agreement

THIS SUPPLY AGREEMENT (HEREINAFTER REFERRED TO AS THE “AGREEMENT”) ENTERED INTO BY:

[             ], a Company incorporated under the Companies Act 1956 and having it’s Registered Office at [    ] (hereinafter referred to as “[             ]” which expression shall wherever the context admits mean and include its successors and assigns) of the One Part:

AND

Varsal, LLC. a company formed in accordance with and by virtue of the laws of the United States and having a registered office at [ ],(hereinafter referred to as “Supplier” or “Varsal” which expression shall wherever the context admits mean and include its successors and assigns) of the Second Part:

WHEREAS:

EX-10.7·S-1·CIK 2109801·ACC 0001493152-26-025296·Filed May 26, 2026, 18:45 ET

EX-10.6

VARSAL TECH, INC.

Exhibit 10.6

THREE-WAY RESEARCH AND PRODUCT DEVELOPMENT AGREEMENT

This Three-Way Research and Product Development Agreement (“Agreement”) is entered into as of July 1, 2018, by and among:

1. VARSAL CHEMICALS (TANGSHAN) CO., LTD., a company organized under the laws of the People’s Republic of China, with its principal place of business at TANGSHAN SEAPORT DEVELOPMENT ZONE, TANGSHAN, HEBEI, CHINA (“Varsalchem Tangshan”);
2. SHANGHAI VARSAL CO., LTD., a company organized under the laws of the People’s Republic of China, with its principal place of business at Suite 1203, No. 939 Jin Qiao Road, Shanghai, China (“Shanghai Varsal”); and
3. VARSAL LLC, a company organized under the laws of the United States of America, with its principal place of business at 363 Ivyland Road, Warminster, PA (“Varsal”).

Collectively, the above parties are referred to as the “Parties,” and individually as a “Party.”

1. Purpose

EX-10.6·S-1·CIK 2109801·ACC 0001493152-26-025296·Filed May 26, 2026, 18:45 ET

EX-10.5

VARSAL TECH, INC.

Exhibit 10.5

RESEARCH AND PRODUCT DEVELOPMENT AGREEMENT

This Research and Product Development Agreement (“Agreement”) is entered into as of July 1, 2018, by and among:

1. Varsal Technology (Tianjin) Co., Ltd., a company organized under the laws of the People’s Republic of China, with its principal place of business at No.12 Qiangwei Road, Tianjin Port Free Trade Zone, Airport Industrial Park, Tianjin, CHINA (“Varsal Tianjin”);
2. VARSAL LLC, a company organized under the laws of the United States of America, with its principal place of business at 363 Ivyland Road, Warminster, PA (“Varsal”).

Collectively, the above parties are referred to as the “Parties,” and individually as a “Party.”

1. Purpose

The purpose of this Agreement is to set forth the terms under which Varsal Tianjin and related parties (together, the “Research Entities”) shall conduct product development research for instruments, laboratory parts, and related products (“Products”) for Varsal.

2. Scope of Research and Development

EX-10.5·S-1·CIK 2109801·ACC 0001493152-26-025296·Filed May 26, 2026, 18:45 ET

EX-10.1

Quanterix Corp

Quanterix

900 Middlesex Turnpike | Building 1

Billerica, MA 01821

Anthony Catalano

Delivered via Email

Re: Employment Agreement

Dear Anthony:

Quanterix Corporation (the "Company") is pleased to offer you the full-time, exempt position of Chief Operations Officer, reporting to Everett Cunningham, Chief Executive Officer. Your start date will be May 14, 2026. This role is required to be in our Billerica, MA office.

Congratulations on this offer and career opportunity with Quanterix!

  1. Base Salary: The Company will pay you a salary at an annual rate of $400,000.00, paid at a bi-weekly rate of $15,384.61 (less all applicable taxes and deductions), subject to periodic review and adjustment at the discretion of the Company.

EX-10.1·8-K·CIK 1503274·ACC 0001503274-26-000024·Filed May 26, 2026, 17:25 ET

EX-10.1

PRECISION BIOSCIENCES INC

PRECISION BIOSCIENCES, INC. 2019 INCENTIVE AWARD PLAN (As Amended and Restated Effective May 21, 2026)

ARTICLE I. PURPOSE

The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in Article XI.

ARTICLE II. ELIGIBILITY

Service Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein.

ARTICLE III. ADMINISTRATION AND DELEGATION

EX-10.1·8-K·CIK 1357874·ACC 0001628280-26-038220·Filed May 26, 2026, 17:20 ET

Exhibit 10.11

BURTECH ACQUISITION CORP II

382 NE 191st Street #952377

Miami, Florida 33179

May 21, 2026

Burtech Acquisition Corp II

5601 Arbor Lane

Coral Gables, FL 33156

Re:          Administrative Services Agreement

Ladies and Gentlemen:

This letter agreement by and between Burtech Acquisition Corp II (the “Company”) and Burtech Sponsor II LLC (“Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on the Nasdaq Global Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):

EX-10.11·8-K·CIK 2098707·ACC 0001213900-26-061109·Filed May 26, 2026, 17:20 ET

INDEMNITY AGREEMENT

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of May 21, 2026 by and between Burtech Acquisition Corp II, a Cayman Islands exempted company (the “Company”), and Scott E. Young (“Indemnitee”).

RECITALS

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, persons who serve the Company and its direct and indirect subsidiaries (collectively, the “Company Group”) to the fullest extent permitted by applicable law;

WHEREAS, this Agreement is a supplement to and in furtherance of the Amended and Restated Memorandum and Articles of Association (the “Charter”) of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

EX-10.10·8-K·CIK 2098707·ACC 0001213900-26-061109·Filed May 26, 2026, 17:20 ET

Exhibit 10.9

INDEMNITY AGREEMENT

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of May 21, 2026 by and between Burtech Acquisition Corp II, a Cayman Islands exempted company (the “Company”), and Sergey Alekseev (“Indemnitee”).

RECITALS

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, persons who serve the Company and its direct and indirect subsidiaries (collectively, the “Company Group”) to the fullest extent permitted by applicable law;

WHEREAS, this Agreement is a supplement to and in furtherance of the Amended and Restated Memorandum and Articles of Association (the “Charter”) of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

EX-10.9·8-K·CIK 2098707·ACC 0001213900-26-061109·Filed May 26, 2026, 17:20 ET

INDEMNITY AGREEMENT

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of May 21, 2026 by and between Burtech Acquisition Corp II, a Cayman Islands exempted company (the “Company”), and Leon Golden (“Indemnitee”).

RECITALS

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, persons who serve the Company and its direct and indirect subsidiaries (collectively, the “Company Group”) to the fullest extent permitted by applicable law;

WHEREAS, this Agreement is a supplement to and in furtherance of the Amended and Restated Memorandum and Articles of Association (the “Charter”) of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

EX-10.8·8-K·CIK 2098707·ACC 0001213900-26-061109·Filed May 26, 2026, 17:20 ET

INDEMNITY AGREEMENT

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of May 21, 2026 by and between Burtech Acquisition Corp II, a Cayman Islands exempted company (the “Company”), and Roman V. Livson (“Indemnitee”).

RECITALS

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, persons who serve the Company and its direct and indirect subsidiaries (collectively, the “Company Group”) to the fullest extent permitted by applicable law;

WHEREAS, this Agreement is a supplement to and in furtherance of the Amended and Restated Memorandum and Articles of Association (the “Charter”) of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

EX-10.7·8-K·CIK 2098707·ACC 0001213900-26-061109·Filed May 26, 2026, 17:20 ET